Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nakazato

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry|May 30, 2001
Synthesis and structure-affinity relationships of 4-(5-Aryl-1,2,3,6-tetrahydropyridino)pyrimidine derivatives as corticotropin-releasing factor(1) receptor antagonistsT Kumagai, T Okubo, H Kataoka-Okubo, et al.
Bioorganic & Medicinal Chemistry|May 30, 2001
Chemical modification of aryl-1,2,3,6-tetrahydropyridinopyrimidine derivative to discover corticotropin-releasing factor(1) receptor antagonists: aryl-1,2,3,6-tetrahydropyridino-purine, -3H-1,2,3-triazolo[4,5-d)pyrimidine, -purin-8-one, and -7H-pyrrolo[2,3-d]pyrimidine derivativesT Kumagai, T Okubo, H Kataoka-Okubo, et al.
Research Communications in Molecular Pathology and Pharmacology|June 13, 2000
In vivo receptor labeling of peripheral benzodiazepine receptor by ex vivo binding of [3H]PK11195T Funakoshi, S Chaki, S Okuyama, et al.
Life Sciences|January 1, 1996
Solubilization and characterization of binding sites for [3H]NE-100, a novel and potent sigma 1 ligand, from guinea pig brainS Chaki, S Okuyama, S Ogawa, et al.
Journal of Medicinal Chemistry|March 26, 1999
Design, synthesis, structure-activity relationships, and biological characterization of novel arylalkoxyphenylalkylamine sigma ligands as potential antipsychotic drugsA Nakazato, K Ohta, Y Sekiguchi, et al.
Bioorganic & Medicinal Chemistry|July 6, 2000
Design, synthesis and structure-affinity relationships of 4-methylidenepiperidine and 4-aryl-1,2,3,6-tetrahydropyridine derivatives as corticotropin-releasing factor1 receptor antagonistsA Nakazato, T Kumagai, T Okubo, et al.
FEBS Letters|March 9, 1999
Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand bindingH Yamamoto, R Miura, T Yamamoto, et al.
European Journal of Pharmacology|June 5, 1999
Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptorsS Chaki, T Funakoshi, R Yoshikawa, et al.
Neuropharmacology|August 26, 1999
In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic, in ratsS Chaki, T Funakoshi, R Yoshikawa, et al.
Chemical & Pharmaceutical Bulletin|June 1, 1993
Structure-activity study of antihypertensive 1,4-dihydropyridine derivatives having nitrooxyalkyl moieties at the 3 and 5 positionsY Kawashima, T Ogawa, M Kato, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry|May 30, 2001
Synthesis and structure-affinity relationships of 4-(5-Aryl-1,2,3,6-tetrahydropyridino)pyrimidine derivatives as corticotropin-releasing factor(1) receptor antagonistsT Kumagai, T Okubo, H Kataoka-Okubo, et al.
Bioorganic & Medicinal Chemistry|May 30, 2001
Chemical modification of aryl-1,2,3,6-tetrahydropyridinopyrimidine derivative to discover corticotropin-releasing factor(1) receptor antagonists: aryl-1,2,3,6-tetrahydropyridino-purine, -3H-1,2,3-triazolo[4,5-d)pyrimidine, -purin-8-one, and -7H-pyrrolo[2,3-d]pyrimidine derivativesT Kumagai, T Okubo, H Kataoka-Okubo, et al.
Research Communications in Molecular Pathology and Pharmacology|June 13, 2000
In vivo receptor labeling of peripheral benzodiazepine receptor by ex vivo binding of [3H]PK11195T Funakoshi, S Chaki, S Okuyama, et al.
Life Sciences|January 1, 1996
Solubilization and characterization of binding sites for [3H]NE-100, a novel and potent sigma 1 ligand, from guinea pig brainS Chaki, S Okuyama, S Ogawa, et al.
Journal of Medicinal Chemistry|March 26, 1999
Design, synthesis, structure-activity relationships, and biological characterization of novel arylalkoxyphenylalkylamine sigma ligands as potential antipsychotic drugsA Nakazato, K Ohta, Y Sekiguchi, et al.
Bioorganic & Medicinal Chemistry|July 6, 2000
Design, synthesis and structure-affinity relationships of 4-methylidenepiperidine and 4-aryl-1,2,3,6-tetrahydropyridine derivatives as corticotropin-releasing factor1 receptor antagonistsA Nakazato, T Kumagai, T Okubo, et al.
FEBS Letters|March 9, 1999
Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand bindingH Yamamoto, R Miura, T Yamamoto, et al.
European Journal of Pharmacology|June 5, 1999
Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptorsS Chaki, T Funakoshi, R Yoshikawa, et al.
Neuropharmacology|August 26, 1999
In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic, in ratsS Chaki, T Funakoshi, R Yoshikawa, et al.
Chemical & Pharmaceutical Bulletin|June 1, 1993
Structure-activity study of antihypertensive 1,4-dihydropyridine derivatives having nitrooxyalkyl moieties at the 3 and 5 positionsY Kawashima, T Ogawa, M Kato, et al.
Pageof 4